Clinical trial
Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In…
NCT00424411 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00424411 |
|---|---|
| Title | Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes |
| Official title | Efficacy and Safety of Inhaled Compared With Subcutaneous Human Insulin Therapy in Subjects With Type 2 Diabetes Mellitus: A Six-Month, Outpatient, Parallel Comparative Trial |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Inhaled human insulin (EXUBERA™) |
| Enrollment | 300 |
| Start date | Sep 1, 1999 |
| Completion | Dec 1, 2000 |
| First posted | Jan 19, 2007 |
| Last update posted | Feb 13, 2007 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: